Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma

Fig. 1

Survival curves for patients with NPC. The overall survival (OS) curves showed that the Weekly group was better than Triweekly group (P = 0.036, there was a significant difference between the groups) (a). The disease-free survival (DFS) curves showed that the Weekly group was better than the Triweekly group (P = 0.028, there was a significant difference between the groups) (b). The distant metastasis-free survival (DMFS) curves (c) and the locoregional relapse-free survival (LRFS) curves (d) revealed no significant difference between the two groups

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us